R C Mohs
Overview
Explore the profile of R C Mohs including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
192
Citations
8203
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Mohs R, Wescourt K, Atkinson R
Mem Cognit
. 2013 Nov;
1(4):443-8.
PMID: 24214639
The Ss memorized a long-term set (LT set) of 20 words before participating in a recognition memory test. On each trial Ss were given a new short-term set (ST set)...
2.
Krumhansl C, Mohs R, Atkinson R
Mem Cognit
. 2011 Feb;
4(4):401-8.
PMID: 21287381
In an experiment employing the symbol-element recognition task (Mohs, Wescourt, & Atkinson, 1975), subjects first learned six lists consisting of four words (elements) each. Each list was associated with a...
3.
Chappell A, Gonzales C, Williams J, Witte M, Mohs R, Sperling R
Neurology
. 2007 Mar;
68(13):1008-12.
PMID: 17389305
Objective: To investigate the efficacy and safety of the positive alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionic acid modulator LY451395 in patients with mild to moderate Alzheimer disease (AD) (Mini-Mental State Examination scores 14 to...
4.
Mohs R
Genes Brain Behav
. 2005 Apr;
4(3):129-33.
PMID: 15810901
This paper describes the natural history of the clinical syndrome of Alzheimer's disease (AD) including the cognitive deficit, the neuropsychiatric symptoms, impact on daily functioning, risk factors, medical complications and...
5.
Parvathy S, Davies P, Haroutunian V, Purohit D, Davis K, Mohs R, et al.
Arch Neurol
. 2001 Dec;
58(12):2025-32.
PMID: 11735776
Context: Accumulation of senile plaques containing amyloid beta (Abeta)-protein is a pathologic hallmark of Alzheimer disease. Amyloid beta-peptide is heterogeneous, with carboxyterminal variants ending at residues Val40 (Abetax-40), Ala42 (Abetax-42),...
6.
Petersen R, Doody R, Kurz A, Mohs R, Morris J, Rabins P, et al.
Arch Neurol
. 2001 Dec;
58(12):1985-92.
PMID: 11735772
The field of aging and dementia is focusing on the characterization of the earliest stages of cognitive impairment. Recent research has identified a transitional state between the cognitive changes of...
7.
Reliability and validity of a chronic care facility adaptation of the Clinical Dementia Rating scale
Marin D, Flynn S, Mare M, Lantz M, Hsu M, Laurans M, et al.
Int J Geriatr Psychiatry
. 2001 Sep;
16(8):745-50.
PMID: 11536340
Objective: This study investigated the reliability and validity of a chronic care facility adaptation of the Clinical Dementia Rating scale (CDR-CC). Method: Sixty-two residents in a chronic care facility participated...
8.
Mohs R, Doody R, Morris J, Ieni J, Rogers S, Perdomo C, et al.
Neurology
. 2001 Aug;
57(3):481-8.
PMID: 11502917
Objective: To examine the effects of donepezil compared with placebo on the preservation of function in patients with AD over a 1-year period. Methods: This was a prospective, 54-week, double-blind,...
9.
Doody R, Stevens J, Beck C, Dubinsky R, Kaye J, Gwyther L, et al.
Neurology
. 2001 May;
56(9):1154-66.
PMID: 11342679
Objective: To define and investigate key issues in the management of dementia and to make literature-based treatment recommendations. Methods: The authors searched the literature for four clinical questions: 1) Does...
10.
Ho L, Purohit D, Haroutunian V, Luterman J, Willis F, Naslund J, et al.
Arch Neurol
. 2001 Mar;
58(3):487-92.
PMID: 11255454
Background: Prior studies have shown that cyclooxygenase 2 (COX-2), an enzyme involved in inflammatory mechanisms and neuronal activities, is up-regulated in the brain with Alzheimer disease (AD) and may represent...